OBJECTIVES The aim of this study was to assess sex-related differences in sporadic cases of arrhythmogenic right ventricular cardiomyopathy (ARVC).
ventricular tachycardia (VT) and/or ventricular fibrillation (VF). The RV functional abnormalities sometimes lead to heart failure (HF) (4) (5) (6) (7) .
Sex has proved important in the characterization and management of a variety of acquired cardiovascular conditions (8) (9) (10) (11) (12) . ARVC is a genetic disorder of intercellular junctions resulting from mutations in certain genes encoding desmosomal proteins (13) (14) (15) (16) (17) (18) (19) (20) , and it is usually inherited in an autosomal dominant pattern. Nevertheless, previous studies have consistently demonstrated that ARVC patients are predominantly male (21) (22) (23) . Moreover, it was reported that the incidence of VT/VF or sudden cardiac death (SCD) was higher in men than in women. However, most previous reports have included significant numbers of family members (23, 24) . Therefore, we investigated the impact of sex on the clinical features and long-term outcome including HF as well as VT/VF in sporadic cases of ARVC.
METHODS STUDY POPULATION.
The study population consisted of 111 consecutive patients with ARVC followed by our institution, the National Cerebral and Cardiovascular Center, Osaka, Japan. All patients were sporadic cases without a family history of ARVC. For patients enrolled before 2010, medical records were reviewed retrospectively and the ARVC diagnosis was re-established according to the revised Task Force criteria (rTFC) (25) , which defines "definite" ARVC as the presence of 2 major criteria, or 1 major criterion plus 2 minor criteria, or 4 or more minor criteria from different categories. Borderline ARVC is defined as the presence of 1 major criterion plus 1 minor criterion, or 3 minor criteria. Finally, possible ARVC is defined as the presence of only 1 major criterion or 2 minor criteria. In the present study, 97 patients (87%) were categorized as definite, 13 patients (12%) as borderline, and only 1 patient (1%) as possible. For the purpose of this study, we excluded the patient considered to have possible ARVC from this study. CMR images were obtained using a 1.5-T system (Magnetom Sonata, Siemens, Erlangen, Germany). The procedures used to acquire the MR images in this study have been previously described (26) . The RVEF obtained by radionuclide angiography was calculated from the backgroundcorrected end-diastolic and end-systolic counts of the first-pass angiogram (27) . First-pass radionuclide angiography was performed using a MultiSPECT3 (Siemens). Ninety-five patients (86%) underwent an electrophysiological study (EPS) including programmed ventricular stimulation. Myocardial biopsy from the RV was performed and samples were histologically analyzed in 72 patients (65%).
ENDPOINTS. Potentially lethal ventricular arrhythmias were composite major arrhythmic events such as VF, sustained VT, or necessary intervention with an implantable cardioverter-defibrillator (ICD) occurring at any time during life including during follow-up. An appropriate ICD intervention was defined as an ICD shock or antitachycardia pacing delivered in response to VT or VF. In addition, the stored electrograms were evaluated by the experts at that time and the events were determined to be appropriate ICD interventions.
Hospitalization for HF was defined as the sudden or gradual onset of the signs or symptoms of New York 
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RESULTS
CLINICAL CHARACTERISTICS. Table 1 shows the clinical characteristics of the 110 ARVC patients at the time of enrollment. There was a predominance of male patients (n ¼ 83; 75%). However, no sex-based differences were shown in age at ARVC diagnosis who underwent an EPS, the inducibility of sustained VT was significantly higher in men than in women (73% vs. 43%; p ¼ 0.02).
MANAGEMENT. Table 2 There were no correlations between the mean cycle length or morphology and sex. Figure 2 shows the Kaplan-Meier analysis regarding cardiac death. There was no significant sex-based difference in the cumulative probability of cardiac death. Figure 3 shows the Kaplan-Meier analysis of VT/VF events during follow-up period and for all-life.
There was no significant sex-based difference in the cumulative probability of VT/VF events during Values are mean AE SD or n (%).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; CRTD ¼ cardiac resynchronization therapy defibrillator; ICD ¼ implantable cardioverter-defibrillator; PM ¼ pacemaker.
FIGURE 1 Causes of Cardiac Deaths in Study Subjects
There were 18 cardiovascular deaths (16%): 7 patients died suddenly; 8 died due to worsening heart failure (HF); 1 died of myocardial infarction; and 2 underwent heart transplantation because of decompensated HF.
Sex-Related Differences in Sporadic ARVC
follow-up period ( Figure 3A) . However, the incidence of VT/VF events was significantly higher in men than in women considering patients' lives since birth ( Figure 3B) . Considering the patients' lifetime risk, male sex was a significant risk factor for VT/VF events (HR: 3.21; 95% CI: 1.84 to 5.97; p <0.0001) ( Table 4 ).
The Kaplan-Meier analysis of HF death or heart transplantation according to sex is shown in Figure 4 . Moreover, we conducted 2 additional analyses to determine the high-risk group of HF in female patients. Figure 5 shows the Kaplan-Meier curves of freedom from the hospitalization for HF during follow-up period according to sex and the age at enrollment. The risk of hospitalization for HF was the highest in female patients ages 50 years or older at enrollment. Figure 6 shows Kaplan-Meier analysis of survival from the hospitalization for HF according to body surface area (BSA) in female patients. The median BSA in women was 1.50 cm 2 (IQR: 1.42 to 1.68 cm 2 ). The female patients with BSA <1.50 cm 2 had a higher risk of hospitalization for HF than did those with BSA 1.50 cm 2 or over.
DISCUSSION
Our study had 3 major findings. First, there was a predominance of male patients (75% of study subjects). Second, male sex was a significant risk factor
FIGURE 2 Kaplan-Meier Analysis Regarding Cardiac Death According to Sex
There was no significant sex-based difference in the cumulative probability of cardiac death. for VT/VF events. Third, the incidence of HF death or heart transplantation due to HF were significantly higher in women than in men. To our knowledge, this is the first study designed to assess the relation between sex and long-term outcome in sporadic ARVC cases with proband status only. ARVC; 67% of these subjects were male. In the present study, we also found a higher prevalence of men among the 110 consecutive ARVC sporadic cases fulfilling the rTFC (25) . In the present study, the prevalence of previous VT/VF and the rate of inducibility of sustained VT during an EPS were higher in men than in women. However, the other clinical manifestations including ECG findings and LV and RV function were comparable in both sexes. The apparent discrepancy between these results may be due to the use of cohort study designs that included significant numbers of family members other than probands; the prognoses of family members, it should be noted, can be affected by the disease severity of the probands. In our study, which examined only proband ARVC patients, we found that men had a significantly higher risk of potentially lethal arrhythmic events than did women during the FIGURE 3 Kaplan-Meier Analysis of VT/VF Events During Follow-Up Period and All-Life (A) There was no significant sex-based difference in the cumulative probability of ventricular tachycardia/ventricular fibrillation (VT/VF) events during the follow-up period. (B) However, the incidence of VT/VF events was significantly higher in male than in female patients considering patients' lives since birth. HR ¼ hazard ratio; TWI ¼ T-wave inversion; other abbreviations as in Tables 1 and 3 . indicates that male subjects typically engage in more exercise than do female subjects (34).
HEART FAILURE. Our data showed that female sex was a risk factor of HF-related clinical deterioration and death in ARVC. HF is an important determinant of clinical prognosis in ARVC patients. In the previous study of the natural history of 130 cases with ARVC, Hulot et al. (35) reported that 24 patients died during the follow-up period and that 59% of these deaths were related to progressive HF. In our study, the incidences of HF death and heart transplantation due to HF were significantly higher in female than in male patients. Furthermore, female sex was an independent predictor of HF-related death or heart transplantation.
One possible mechanism for the sex-based differences is related to the reaction to volume overload and influence of thoracic size. Fitzpatrick et al. (36) analyzed a series of 266 LV assist device recipients and found that a biventricular assist device was re- Female patients had a significantly higher risk of heart failure (HF) death or heart transplantation due to HF than did male patients (p ¼ 0.003). Moreover, many changes of therapy occurred for each patient during the follow-up.
Second, in our cohort of sporadic cases of ARVC, a family history of sudden death was found to be present in about 14% of all patients. We did not have complete information on the causes of these events, and they may include undiagnosed cases of ARVC.
However, it is unlikely that any undetected family history of ARVC would substantially change the overall results because there were no significant sex-based differences related to family history of sudden death. The risk of hospitalization for heart failure (HF) was the highest in female patients age 50 years or older at enrollment. The female patients with body surface area (BSA) <1.50 cm 2 had a higher risk of hospitalization for heart failure (HF) than did those with BSA of 1.50 cm 2 or over (p ¼ 0.04).
Third, subjects who experienced SCD at a young age before diagnosis were unavoidably not included in our analysis of lifetime arrhythmic events and SCD.
However, it is noteworthy that the majority (67%) of young SCD victims with ARVC were male (3), which further suggests an association between male sex and increased risk of potentially lethal arrhythmic events.
Fourth, a genetic study in ARVC patients would be clinically significant; however, only 14 patients underwent genetic testing in the study population.
Therefore, we could not determine the relationship between the genotype and its clinical impact on the arrhythmic and HF outcome. Fujishiro-dai, Suita, Osaka 565-8565, Japan. E-mail:
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